appointment
GSK’s Simon Jose to be next ABPI president
January 29, 2010Sales and Marketing ABPI, Simon Jose, appointment, sales and marketing
UK pharma industry association the ABPI has named GSK’s UK general manager Simon Jose its next president. He will take …
ScopeMedical appoints Jennifer Duffy and Andrew Wightman
January 28, 2010Medical Communications ScopeMedical, appointment, medical communications
ScopeMedical has appointed new medical writer Jennifer Duffy (pictured left) and events manager Andrew Wightman. Jennifer has an MSc in …
Cell Medica bolsters senior management
January 28, 2010Research and Development Cell Medica, appointment, research and development
London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …
BioCeramic Therapeutics appoints Ian Brown
January 27, 2010Research and Development BioCeramic Therapeutics, appointment, research and development
BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …
National clinical directors appointed
January 26, 2010NHS, UK, appointment, dementia, elderly, liver disease
A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …
Merck appoints UK leadership team
January 26, 2010MSD, Merck & Co, appointment
Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …
Clavis Pharma appoints Olav Hellebø
January 25, 2010Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …
PDS appoints Graham Clapperton
January 22, 2010Research and Development PDS, appointment, research and development
Pharmaceutical Development Services Ltd (PDS) has appointed Graham Clapperton to head up its quality services. Graham joins the Nottingham, UK-based consultancy …
Clive Dix appointed chairman of Crescendo Biologics
January 21, 2010Research and Development Crescendo Biologics, appointment, research and development
Cambridge, UK-based Crescendo Biologics has appointed Clive Dix as chairman. He will work closely with chief scientific officer Mike Romanos …
Lisa Pantelli joins Spink
January 21, 2010Medical Communications Spink, appointment, medical communications
Healthcare PR agency Spink has hired Lisa Pantelli for its rapidly expanding consumer healthcare division. With over six years blue …
Peter Belden appointed MD of Brecon Pharmaceuticals
January 20, 2010Manufacturing and Production Brecon, appointment, manufacturing and production
Commercial packaging and clinical trials supplies services company Brecon Pharmaceuticals has appointed Peter Belden managing director. He was previously senior …
Dr Kai Lindevall re-appointed chief executive of Encorium
January 20, 2010Research and Development Encorium, appointment, research and development
Dr Kai Lindevall has been re-appointed chief executive of contract research organisation (CRO) Encorium, having held the post in 2008 …
Dr Lloyd Payne joins Aquapharm Biodiscovery as research director
January 20, 2010Research and Development Aquapharm Biodiscovery, appointment, research and development
Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Dr Lloyd Payne as its new research director. He joins Aquapharm from …
Chamberlain Healthcare PR appoints Mark Cater
January 20, 2010Medical Communications Chamberlain Healthcare PR, appointment, medical communications
Mark Cater has been appointed managing director of Chamberlain Healthcare PR’s London office. Prior to joining Chamberlain, Cater was regional …
Sir Leszek Borysiewicz to step down from the MRC
January 19, 2010MRC, UK, appointment
The Medical Research Council’s chief executive Sir Leszek Borysiewicz is stepping down later this year to become vice chancellor of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
